141 related articles for article (PubMed ID: 7573350)
1. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.
Busam KJ; Berwick M; Blessing K; Fandrey K; Kang S; Karaoli T; Fine J; Cochran AJ; White WL; Rivers J
Am J Pathol; 1995 Oct; 147(4):1049-56. PubMed ID: 7573350
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.
Srivastava A; Laidler P; Davies RP; Horgan K; Hughes LE
Am J Pathol; 1988 Nov; 133(2):419-23. PubMed ID: 3189515
[TBL] [Abstract][Full Text] [Related]
3. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay.
Rongioletti F; Miracco C; Gambini C; Pastorino A; Tosi P; Rebora A
Am J Dermatopathol; 1996 Oct; 18(5):474-7. PubMed ID: 8902093
[TBL] [Abstract][Full Text] [Related]
4. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.
Kashani-Sabet M; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR
J Clin Oncol; 2002 Apr; 20(7):1826-31. PubMed ID: 11919240
[TBL] [Abstract][Full Text] [Related]
5. Influence of tumor thickness and vascularity on survival in cutaneous melanoma.
Zamolo G; Gruber F; Cabrijan L; Micović V; Iternicka Z; Jonjić N
Acta Med Okayama; 2001 Oct; 55(5):289-93. PubMed ID: 11688952
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
7. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.
Piérard GE; Piérard-Franchimont C
Eur J Cancer; 1997 Oct; 33(11):1888-92. PubMed ID: 9470852
[TBL] [Abstract][Full Text] [Related]
8. The vascularity of primary cutaneous melanoma.
Fallowfield ME; Cook MG
J Pathol; 1991 Jul; 164(3):241-4. PubMed ID: 1890549
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis.
Massi D; Franchi A; Borgognoni L; Paglierani M; Reali UM; Santucci M
Virchows Arch; 2002 Jan; 440(1):22-8. PubMed ID: 11942572
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascularity in cutaneous melanoma: pilot study using in vivo confocal scanning laser microscopy.
Humphrey S; Walsh NM; Delaney L; Propperova I; Langley RG
J Cutan Med Surg; 2006; 10(3):122-7. PubMed ID: 17241587
[TBL] [Abstract][Full Text] [Related]
11. Vascular retardation in dormant growth-stunted malignant melanomas.
Piérard-Franchimont C; Henry F; Heymans O; Piérard GE
Int J Mol Med; 1999 Oct; 4(4):403-6. PubMed ID: 10493982
[TBL] [Abstract][Full Text] [Related]
12. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
13. Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill RL; Levy MA
Am J Pathol; 1993 Jul; 143(1):99-104. PubMed ID: 7686347
[TBL] [Abstract][Full Text] [Related]
14. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour.
Srivastava A; Hughes LE; Woodcock JP; Laidler P
Br J Cancer; 1989 Jan; 59(1):89-91. PubMed ID: 2667611
[TBL] [Abstract][Full Text] [Related]
15. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma.
Thies A; Mangold U; Moll I; Schumacher U
J Pathol; 2001 Dec; 195(5):537-42. PubMed ID: 11745688
[TBL] [Abstract][Full Text] [Related]
16. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
17. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.
Carnochan P; Briggs JC; Westbury G; Davies AJ
Br J Cancer; 1991 Jul; 64(1):102-7. PubMed ID: 1854608
[TBL] [Abstract][Full Text] [Related]
18. Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis.
Smolle J; Soyer HP; Hofmann-Wellenhof R; Smolle-Juettner FM; Kerl H
Pathol Res Pract; 1989 Nov; 185(5):740-5. PubMed ID: 2696951
[TBL] [Abstract][Full Text] [Related]
19. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
20. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases.
Barnhill RL; Piepkorn MW; Cochran AJ; Flynn E; Karaoli T; Folkman J
Arch Dermatol; 1998 Aug; 134(8):991-4. PubMed ID: 9722729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]